• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中坏死性凋亡相关预后标志物的构建、免疫组化验证及其与肿瘤免疫浸润的关联

Construction and immunohistochemical validation of a necroptosis-related prognostic signature in bladder cancer and its association with tumor immune infiltration.

作者信息

Wang Tao, Ding Fei, Sun Kai

机构信息

Department of Oncology, Lanzhou University Second Hospital, Lanzhou, China.

Department of Obstetrics and Gynecology, Gansu Provincial Maternal and Child Healthcare Hospital, Lanzhou, China.

出版信息

Front Genet. 2025 Aug 14;16:1527907. doi: 10.3389/fgene.2025.1527907. eCollection 2025.

DOI:10.3389/fgene.2025.1527907
PMID:40893939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12391097/
Abstract

BACKGROUND

Bladder urothelial carcinoma (BLCA) represents a highly malignant neoplasm with significant clinical challenges. Necroptosis, a programmed form of cell death, exhibits dual regulatory functions in both tumor immunomodulation and oncogenesis. The precise mechanistic involvement of necroptosis-related genes (NRGs) in BLCA pathogenesis remains poorly characterized, prompting our systematic investigation of their potential biological and clinical significance.

METHODS AND RESULTS

We performed comprehensive bioinformatics analyses utilizing integrated datasets from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation, we curated 159 NRGs and subsequently identified 25 differentially expressed genes functionally implicated in necrotic cell death and extrinsic apoptotic pathways, specifically including influenza A signaling, NOD-like receptor cascades, and related biological processes. Univariate Cox proportional hazards modeling coupled with LASSO regression analysis revealed five prognostically significant NRGs ( and ). Based on these genes, we developed a robust prognostic model that can stratify patients into high- and low-risk categories, each exhibiting distinct survival outcomes. This model demonstrated moderate accuracy in prognosis prediction. Immunohistochemical validation in BLCA specimens confirmed dysregulated expression patterns of these five NRGs. Additional analyses uncovered significant correlations between NRG expression profiles and various immunological parameters, including immune cell infiltration patterns and immune checkpoint molecule expression.

CONCLUSION

Our study delineates a novel five-gene NRG signature with robust prognostic value in BLCA. These gene determinants appear to critically influence both tumor progression and immune microenvironment, thereby representing promising candidates for therapeutic targeting and future mechanistic exploration in bladder cancer biology.

摘要

背景

膀胱尿路上皮癌(BLCA)是一种具有重大临床挑战的高度恶性肿瘤。坏死性凋亡是一种程序性细胞死亡形式,在肿瘤免疫调节和肿瘤发生中均表现出双重调节功能。坏死性凋亡相关基因(NRGs)在BLCA发病机制中的精确机制参与仍不清楚,促使我们对其潜在的生物学和临床意义进行系统研究。

方法和结果

我们利用来自癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)的整合数据集进行了全面的生物信息学分析。通过京都基因与基因组百科全书(KEGG)通路注释,我们整理了159个NRGs,随后鉴定出25个在坏死性细胞死亡和外源性凋亡途径中具有功能牵连的差异表达基因,具体包括甲型流感信号传导、NOD样受体级联反应及相关生物学过程。单变量Cox比例风险模型与LASSO回归分析相结合,揭示了五个具有预后意义的NRGs(和)。基于这些基因,我们开发了一个强大的预后模型,该模型可以将患者分为高风险和低风险类别,每个类别都表现出不同的生存结果。该模型在预后预测中显示出中等准确性。BLCA标本中的免疫组织化学验证证实了这五个NRGs的表达模式失调。进一步的分析发现NRG表达谱与各种免疫参数之间存在显著相关性,包括免疫细胞浸润模式和免疫检查点分子表达。

结论

我们的研究描绘了一种在BLCA中具有强大预后价值的新型五基因NRG特征。这些基因决定因素似乎对肿瘤进展和免疫微环境都有至关重要的影响,因此代表了膀胱癌生物学中治疗靶点和未来机制探索的有希望的候选者。

相似文献

1
Construction and immunohistochemical validation of a necroptosis-related prognostic signature in bladder cancer and its association with tumor immune infiltration.膀胱癌中坏死性凋亡相关预后标志物的构建、免疫组化验证及其与肿瘤免疫浸润的关联
Front Genet. 2025 Aug 14;16:1527907. doi: 10.3389/fgene.2025.1527907. eCollection 2025.
2
Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade Glioma.用于预测原发性低级别胶质瘤预后和免疫特征的免疫相关基因特征的系统分析
Biomed Res Int. 2025 Aug 12;2025:6180391. doi: 10.1155/bmri/6180391. eCollection 2025.
3
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
4
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy.基于坏死性凋亡基因构建肺腺癌预后模型及其肿瘤免疫治疗潜力探索
Transl Cancer Res. 2025 May 30;14(5):2563-2579. doi: 10.21037/tcr-24-2165. Epub 2025 May 26.
5
Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer.乳酰化预后特征将DHCR7鉴定为膀胱癌化疗耐药和免疫治疗疗效的调节因子。
Front Immunol. 2025 Jul 15;16:1585727. doi: 10.3389/fimmu.2025.1585727. eCollection 2025.
6
Prognostic Implications and Immune Landscape Analysis of Necroptosis-associated Gene Signatures in Acute Myeloid Leukemia.急性髓系白血病中坏死性凋亡相关基因特征的预后意义及免疫景观分析
J Cancer. 2025 Jul 11;16(10):3202-3215. doi: 10.7150/jca.113136. eCollection 2025.
7
Construction and validation of a lipid metabolism-related genes prognostic signature for skin cutaneous melanoma.皮肤黑色素瘤脂质代谢相关基因预后特征的构建与验证
Biochem Biophys Res Commun. 2025 May 29;775:152115. doi: 10.1016/j.bbrc.2025.152115.
8
The relationship between immune cell infiltration and necroptosis gene expression in sepsis: an analysis using single-cell transcriptomic data.脓毒症中免疫细胞浸润与坏死性凋亡基因表达的关系:基于单细胞转录组数据的分析
Front Cell Infect Microbiol. 2025 Aug 11;15:1618438. doi: 10.3389/fcimb.2025.1618438. eCollection 2025.
9
Construction and validation of a prognostic model for glioma: an analysis based on mismatch repair-related genes and their correlation with clinicopathological features.胶质瘤预后模型的构建与验证:基于错配修复相关基因及其与临床病理特征相关性的分析
Transl Cancer Res. 2025 May 30;14(5):2690-2706. doi: 10.21037/tcr-24-2045. Epub 2025 May 9.
10
A novel fumaric acid metabolism-related prognostic signature associated with prognosis and immune infiltration landscape in laryngeal squamous cell carcinoma.一种与喉鳞状细胞癌预后及免疫浸润格局相关的新型富马酸代谢相关预后特征。
Transl Cancer Res. 2025 Jul 30;14(7):3991-4008. doi: 10.21037/tcr-2025-29. Epub 2025 Jul 25.

本文引用的文献

1
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity.靶向程序性细胞死亡:细胞凋亡、坏死性凋亡、焦亡、铁死亡和铜死亡在抗癌免疫中的作用
J Transl Int Med. 2025 Mar 19;13(1):10-32. doi: 10.1515/jtim-2025-0004. eCollection 2025 Feb.
2
Exploring the Anti-Colorectal Cancer Mechanism of Norcantharidin Through TRAF5/NF-κB Pathway Regulation and Folate-Targeted Liposomal Delivery.通过TRAF5/NF-κB通路调控和叶酸靶向脂质体递送探索去甲斑蝥素的抗结直肠癌机制
Int J Mol Sci. 2025 Feb 9;26(4):1450. doi: 10.3390/ijms26041450.
3
CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway.
CHMP4C通过RIPK1/RIPK3/MLKL途径抑制坏死性凋亡,从而促进胰腺癌进展。
J Adv Res. 2025 Jan 25. doi: 10.1016/j.jare.2025.01.040.
4
Comparative evaluation of PD-L1 expression and tumor immune microenvironment in molecular subtypes of muscle-invasive bladder cancer and its correlation with survival outcomes.肌层浸润性膀胱癌分子亚型中PD-L1表达与肿瘤免疫微环境的比较评估及其与生存结果的相关性
Am J Clin Pathol. 2025 May 17;163(5):708-722. doi: 10.1093/ajcp/aqae176.
5
IL-33 in cancer immunotherapy: Pleiotropic functions and biological strategies.白细胞介素-33在癌症免疫治疗中的多效性功能及生物学策略
Cytokine Growth Factor Rev. 2024 Nov 22. doi: 10.1016/j.cytogfr.2024.11.005.
6
Induced Necroptosis and Its Role in Cancer Immunotherapy.诱导细胞坏死性凋亡及其在癌症免疫治疗中的作用。
Int J Mol Sci. 2024 Oct 6;25(19):10760. doi: 10.3390/ijms251910760.
7
Tumor immune microenvironment dynamics and outcomes of prognosis in non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌的肿瘤免疫微环境动态变化及预后结果
Cancer Sci. 2024 Dec;115(12):3963-3972. doi: 10.1111/cas.16333. Epub 2024 Oct 11.
8
Necroptosis in immunity, tissue homeostasis, and cancer.细胞坏死性凋亡在免疫、组织稳态和癌症中的作用。
Curr Opin Immunol. 2024 Aug;89:102455. doi: 10.1016/j.coi.2024.102455. Epub 2024 Aug 20.
9
The Role of IRF9 Upregulation in Modulating Sensitivity to Olaparib and Platinum-Based Chemotherapies in Breast Cancer.IRF9 上调在调节乳腺癌对奥拉帕利和铂类化疗药物敏感性中的作用。
Genes (Basel). 2024 Jul 22;15(7):959. doi: 10.3390/genes15070959.
10
Recognition of necroptosis: From molecular mechanisms to detection methods.坏死性凋亡的识别:从分子机制到检测方法。
Biomed Pharmacother. 2024 Sep;178:117196. doi: 10.1016/j.biopha.2024.117196. Epub 2024 Jul 24.